Kalaris Therapeutics, Inc. (KLRS) › Shares OutstandingKalaris Therapeutics, Inc. (KLRS) — Shares OutstandingAnnual figures by period end, from SEC filings.2019-12-31: 2.10M2020-12-31: 61.93M2021-12-31: 63.57M2022-12-31: 93.09M2023-12-31: 4.96M2024-12-31: 1.36M2025-12-31: 22.90M22.90M2019-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3122.90M+1588.4%2026-03-17Balance as of period end2024-12-311.36M-72.7%2026-03-17Balance as of period end2023-12-314.96M-94.7%2025-03-07Balance as of period end2022-12-3193.09M+46.5%2024-03-15Balance as of period end2021-12-3163.57M+2.6%2023-02-15Balance as of period end2020-12-3161.93M+2849.5%2022-02-10Balance as of period end2019-12-312.10M—2021-02-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)